Skip to main content
Download PDF

Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma

Molecular Cancer volume 20, Article number: 155 (2021) Cite this article

The Original Article was published on 05 November 2021

Correction to: Mol Cancer 20, 142 (2021).

https://doi.org/10.1186/s12943-021-01443-2

Following the publication of the original article [1], the authors found out that the Additional file 1 is outdated. Updated version is contained on this article, see Additional file section.

The original article has been corrected.

Reference

  1. Mao W, Wang K, Xu B, et al. ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma. Mol Cancer. 2021;20:142. https://doi.org/10.1186/s12943-021-01443-2.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Weipu Mao, Keyi Wang, Bin Xu and Hui Zhang contributed equally to this work.

Authors and Affiliations

  1. Department of Urology, Affiliated Zhongda Hospital of Southeast University, No. 87 Dingjiaqiao, Hunan Road, Gulou District, Nanjing, 210009, China

    Weipu Mao, Bin Xu, Si Sun, Qiang Hu, Lei Zhang, Chunhui Liu, Shuqiu Chen, Jianping Wu & Ming Chen

  2. Surgical Research Center, Institute of Urology, Southeast University Medical School, Nanjing, 210009, China

    Weipu Mao, Bin Xu & Ming Chen

  3. Department of Urology, Nanjing Lishui District People’s Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, China

    Weipu Mao & Ming Chen

  4. Department of Urology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, No. 301, Yanchang Road, Jing’an District, Shanghai, 200072, China

    Keyi Wang, Wei Li & Bo Peng

  5. Department of Anesthesiology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, 200072, China

    Hui Zhang

Authors
  1. Weipu Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keyi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bin Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hui Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Si Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qiang Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chunhui Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shuqiu Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jianping Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Ming Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Wei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Bo Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Bin Xu, Ming Chen, Wei Li or Bo Peng.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mao, W., Wang, K., Xu, B. et al. Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma. Mol Cancer 20, 155 (2021). https://doi.org/10.1186/s12943-021-01459-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12943-021-01459-8

Molecular Cancer

ISSN: 1476-4598